These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12581614)

  • 1. An editorial for the HIV infected: immune regulation. The implications for treatment of HIV infection and the potential role of T cell suppressor pathways instead of apopstasis, anergy or direct CD4 T cell deletion in AIDS pathogenesis.
    Wendel TD
    Med Hypotheses; 2003 Mar; 60(3):373-81. PubMed ID: 12581614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientists, activists sue South Africa's AIDS 'denialists'.
    Watson J
    Nat Med; 2006 Jan; 12(1):6. PubMed ID: 16397537
    [No Abstract]   [Full Text] [Related]  

  • 4. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction.
    Heeney J; Jonker R; Koornstra W; Dubbes R; Niphuis H; Di Rienzo AM; Gougeon ML; Montagnier L
    J Med Primatol; 1993; 22(2-3):194-200. PubMed ID: 8105093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriëns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected persons.
    Geertsma MF; van Wengen-Stevenhagen A; van Dam EM; Risberg K; Kroon FP; Groeneveld PH; Nibbering PH
    J Infect Dis; 1999 Sep; 180(3):649-58. PubMed ID: 10438351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS vaccines. Immune Response Corp.--take two.
    Cohen J
    Science; 1994 Jun; 264(5164):1402. PubMed ID: 7910980
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
    Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
    Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
    Schnittman SM; Fauci AS
    Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decline in total T cell count is associated with onset of AIDS, independent of CD4(+) lymphocyte count: implications for AIDS pathogenesis.
    Margolick JB; Donnenberg AD; Chu C; O'Gorman MR; Giorgi JV; Muñoz A
    Clin Immunol Immunopathol; 1998 Sep; 88(3):256-63. PubMed ID: 9743612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1995 outlook: research strategy.
    James JS
    AIDS Treat News; 1995 Jan; (No 215):5-7. PubMed ID: 11362216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spreading of HIV-1 infection in the human organism is caused by fractalkine trafficking of the infected lymphocytes--a review, hypothesis and implications for treatment.
    Becker Y
    Virus Genes; 2007 Apr; 34(2):93-109. PubMed ID: 17151939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
    Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance.
    Miedema F
    Immunodefic Rev; 1992; 3(3):173-93. PubMed ID: 1354968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed cell death in AIDS-related HIV and SIV infections.
    Gougeon ML; Garcia S; Heeney J; Tschopp R; Lecoeur H; Guetard D; Rame V; Dauguet C; Montagnier L
    AIDS Res Hum Retroviruses; 1993 Jun; 9(6):553-63. PubMed ID: 8102239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible roles of sperm and sperm antibodies in the pathogenesis and treatment of AIDS.
    Eldor J
    Med Hypotheses; 1995 Mar; 44(3):155-8. PubMed ID: 7609666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals.
    Ng TT; Kanner SB; Humphries MJ; Wickremasinghe RG; Nye KE; Anderson J; Khoo SH; Morrow WJ
    J Immunol; 1997 Mar; 158(6):2984-99. PubMed ID: 9058838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of disease progression in HIV-infected homosexual men with CD4+ cells < 200 x 10(6)/l but free of AIDS-defining clinical disease.
    Keet IP; Krol A; Koot M; Roos MT; de Wolf F; Miedema F; Coutinho RA
    AIDS; 1994 Nov; 8(11):1577-83. PubMed ID: 7848594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.